You are here

Article Text

Article menu
Download PDFPDF
DTB select
MHRA advises monitoring blood concentrations of clozapine and other antipsychotics

Abstract

Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers’ attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned.

  • health care quality
  • access
  • evaluation
  • drug-related side effects and adverse reactions

https://doi.org/10.1136/dtb.2020.000073

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Overview of Medicines and Healthcare products Regulatory Agency. Clozapine and other antipsychotics: monitoring blood concentrations for toxicity. Drug Safety Update 2020;14(1):2.

    • Contributors DTB Team.

    • Provenance and peer review Commissioned; internally peer reviewed.